NOVARTIS AG

NVS

160.2500.04% ( -0.070 )

Closed: Nov 12, 15:59:59 (EDT)

Current ValuationThe current P/E ratio is 30.18, above the reasonable range, cheaper than 5.45% of the time in the past 5 years, and the industry ranks 45/257, the industry Median -0.98.

30.18xP/E

Stock price$160.32Earnings per share$5.31

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

03774111148

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x20x40x60x80x100x

P/E ratio
Name/Symbol
NVSUSNOVARTIS AG	30.18x	4.94%	$302.78B
ETONUSEton Pharmaceuticals	39.56x	1,282.35%	$1.97B
PCRXUSPacira BioSciences	38.52x	302.08%	$1.45B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.